SAM
TXG icon

Smartleaf Asset Management’s 10x Genomics TXG Stock Holding History

Smartleaf Asset Management’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$27.6K Hold
743
– – ﹤0.01% 1838
2026
Q1 		$14.7K Buy
743
+208
+39% +$4.16K ﹤0.01% 2127
2025
Q4 		$8.71K Buy
535
+439
+457% +$6.63K ﹤0.01% 2455
2025
Q3 		$1.09K Buy
+96
New +$1.25K ﹤0.01% 2729
2025
Q2 		– Sell
-26
Closed -$238 – 2972
2025
Q1 		$238 Buy
26
+25
+2,500% +$315 ﹤0.01% 2776
2024
Q4 		$14 Sell
1
-478
-100% -$7.54K ﹤0.01% 2913
2024
Q3 		$10.9K Buy
479
+432
+919% +$8.93K ﹤0.01% 1705
2024
Q2 		$932 Buy
47
+2
+4% +$52 ﹤0.01% 2437
2024
Q1 		$1.66K Buy
45
+17
+61% +$747 ﹤0.01% 1506
2023
Q4 		$1.61K Buy
+28
New +$1.22K ﹤0.01% 994

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Smartleaf Asset Management's TXG Position: Q2 2026 in Review

Smartleaf Asset Management held its 10x Genomics (TXG) position steady in Q2 2026 at 743 shares worth $27.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1838.

Smartleaf Asset Management first reported a position in TXG in Q4 2023 and has held it in 10 quarters since. 390 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • Smartleaf Asset Management held 743 shares of 10x Genomics worth $27.6K as of Q2 2026.
  • Smartleaf Asset Management left its 10x Genomics share count unchanged in Q2 2026.
  • 10x Genomics made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q2 2026, its #1838 holding.
  • Smartleaf Asset Management first reported a position in 10x Genomics in Q4 2023 and has held it in 10 quarters since.
  • 390 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Smartleaf Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.